How have BEAM and IRON total returns compared?

Over the past 5 years, BEAM delivered -21.41% and IRON delivered 10.70% annualized total return. Past performance doesn't predict future results.

Beam Therapeutics Inc. (BEAM) vs Disc Medicine, Inc. (IRON)

A side-by-side comparison of Beam Therapeutics Inc. and Disc Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BEAM

Beam Therapeutics Inc.

$2.58B

$25.09HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

IRON

Disc Medicine, Inc.

$2.37B

$61.80HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — BEAM vs IRON

growth of $100 · dividends reinvested · last 6y

BEAM +15.2% (+2.4%/yr)IRON -38.5% (-7.8%/yr)BEAM compounded faster over this window

BEAM IRON

BEAM vs IRON: by the numbers

•BEAM is the larger company ($2.58B vs $2.37B market cap).
•Both run net losses; IRON's is the smaller (0.00% vs -54.75% net margin).

Metrics side by side

Valuation

Metric	BEAM	IRON
P/S ratio	16.54	N/A
P/B ratio	2.42	3.68

Profitability

Metric	BEAM	IRON
Gross margin	84.05%	0.00%
Operating margin	-274.57%	0.00%
Net margin	-54.75%	0.00%
ROE	-8.00%	-38.17%
ROIC	-28.96%	-38.21%

Growth (annualized)

Metric	BEAM	IRON
Revenue CAGR (5Y)	479.04%	N/A
Total return CAGR (5Y)	-21.41%	10.70%

Frequently asked

How have BEAM and IRON total returns compared?: Over the past 5 years, BEAM delivered -21.41% and IRON delivered 10.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BEAM analysis Full IRON analysis Interactive comparison tool

Dig into the metrics

Beam Therapeutics ROE Disc Medicine ROE Beam Therapeutics operating margin Disc Medicine operating margin Beam Therapeutics revenue growth Disc Medicine revenue growth Beam Therapeutics free cash flow Disc Medicine free cash flow

Beam Therapeutics & Disc Medicine appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.